Shared on19 May 25Fair value Decreased 1.86%
Zwfis made no meaningful changes to valuation assumptions.
Loading...
Protalix BioTherapeutics aims for $3.20 by year-end amidst strong revenue growth
Zwfis's Fair Value
US$4.23
45.4% undervalued intrinsic discount19 May
US$2.31
1Y
124.3%7D
-3.8%1Y
124.3%7D
-3.8%You can edit this narrative until May 19 5:05 PM. Then, changes will post as Updates.